Robotics Welcome
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
JC Gutiérrez-Ramos, President and CEO, Synlogic
Ali Merchant, President and CEO, iQ3Connect
P&G is looking for a number of solutions to improve human-robot collaboration and safety. There are three distinct use cases: highly reliable object detection, deterministic localization for mobile robots, and highly reliable recognition of humans.
Interpretable AI co-founders, Jack Dunn and Daisy Zhuo